Healthcare provider profile · identity verified

Norman Seaholm, MD

Family Practice · TACOMA, WA · NPI 1780604272

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	465	123
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	300	43
Levothyroxine Sodium	Levothyroxine Sodium	289	71
Amlodipine Besylate	Amlodipine Besylate	251	68
Lisinopril	Lisinopril	229	67
Omeprazole	Omeprazole	225	60
Metoprolol Succinate	Metoprolol Succinate	198	43
Metformin Hcl	Metformin Hcl	165	43
Losartan Potassium	Losartan Potassium	164	46
Hydrochlorothiazide	Hydrochlorothiazide	162	50
Gabapentin	Gabapentin	157	37
Rosuvastatin Calcium	Rosuvastatin Calcium	142	40
Alprazolam	Alprazolam	137	22
Albuterol Sulfate Hfa	Albuterol Sulfate	136	53
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	134	31
Trazodone Hcl	Trazodone Hcl	133	32
Xarelto	Rivaroxaban	132	16
Potassium Chloride	Potassium Chloride	118	36
Pantoprazole Sodium	Pantoprazole Sodium	110	32
Metformin Hcl Er	Metformin Hcl	108	29
Alendronate Sodium	Alendronate Sodium	95	25
Prednisone	Prednisone	92	47
Citalopram Hbr	Citalopram Hydrobromide	89	15
Tamsulosin Hcl	Tamsulosin Hcl	84	27
Furosemide	Furosemide	83	24
Clopidogrel	Clopidogrel Bisulfate	82	23
Carvedilol	Carvedilol	81	22
Oxycodone Hcl	Oxycodone Hcl	79	20
Atenolol	Atenolol	78	19
Sertraline Hcl	Sertraline Hcl	70	22
Fluticasone Propionate	Fluticasone Propionate	66	25
Simvastatin	Simvastatin	65	20
Aripiprazole	Aripiprazole	64	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	64	17
Quetiapine Fumarate	Quetiapine Fumarate	60	suppressed
Glimepiride	Glimepiride	57	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	15
Meloxicam	Meloxicam	56	15
Metoprolol Tartrate	Metoprolol Tartrate	55	12
Lorazepam	Lorazepam	54	18
Fluoxetine Hcl	Fluoxetine Hcl	53	18
Diazepam	Diazepam	52	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	18
Eliquis	Apixaban	50	13
Duloxetine Hcl	Duloxetine Hcl	49	suppressed
Bupropion Xl	Bupropion Hcl	47	12
Glipizide	Glipizide	45	14
Lovastatin	Lovastatin	45	13
Ozempic	Semaglutide	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	11
Repaglinide	Repaglinide	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Mirtazapine	Mirtazapine	40	suppressed
Spironolactone	Spironolactone	40	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Estradiol	Estradiol	38	suppressed
Pregabalin	Pregabalin	37	suppressed
Methadone Hcl	Methadone Hcl	36	suppressed
Mounjaro	Tirzepatide	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	30
Famotidine	Famotidine	33	11
Methocarbamol	Methocarbamol	33	11
Tizanidine Hcl	Tizanidine Hcl	33	15
Topiramate	Topiramate	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Ondansetron Odt	Ondansetron	32	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	12
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Mupirocin	Mupirocin	31	23
Allopurinol	Allopurinol	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	18
Warfarin Sodium	Warfarin Sodium	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	20
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Nystatin	Nystatin	26	13
Torsemide	Torsemide	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Azithromycin	Azithromycin	20	14
Ibuprofen	Ibuprofen	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Finasteride	Finasteride	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valsartan	Valsartan	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	14
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Cephalexin	Cephalexin	12	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Naproxen	Naproxen	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Temazepam	Temazepam	12	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	12	12
Acyclovir	Acyclovir	11	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error